Daré Bioscience, Inc. (DARE)

Daré Bioscience Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-30.16	-30.95	-38.7	-27.41	-15.05
Depreciation & Amortization	0.09	0.05	-0.07	-0.12	-0.02
Share-Based Compensation	2.53	2.16	1.6	0.74	0.46
Other Operating Activities	-11.32	10.65	8.4	1.54	0.5
Operating Cash Flow	-38.86	-18.09	-28.76	-25.23	-13.32
Capital Expenditures	-0.63	-0.06	-0.01	-0.02	0
Acquisitions	0	0	0	0	6.14
Investing Cash Flow	-0.63	-0.06	-0.01	-0.02	6.14
Share Issuance / Repurchase	10.65	1.34	75.85	24.76	5.15
Debt Issued / Paid	0.27	0	0	0.37	0
Other Financing Activities	4.72	-	-	-	-
Financing Cash Flow	15.64	1.34	75.85	25.13	5.15
Exchange Rate Effect	-0.01	-0.2	-0.06	0.01	-0.01
Net Cash Flow	-23.86	-17	47	-0.11	-2.03
Free Cash Flow	-39.49	-18.15	-28.78	-25.25	-13.32
Free Cash Flow Margin	-1406.26%	-181.51%	-	-	-
Free Cash Flow Per Share	-5.43	-2.58	-5.65	-10.07	-10.26

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).